Evaluation of the Effect of Virtual Reality Application on Postoperative Pain and Anxiety in Women Aged 50-70
Launched by OSMANIYE KORKUT ATA UNIVERSITY · May 28, 2024
Trial Information
Current as of July 03, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how virtual reality (VR) can help manage pain and anxiety in women aged 50 to 70 after certain surgeries, like knee replacements or hysterectomies. The idea is that by using VR, patients can be taken to a different, relaxing environment, which may help distract them from pain and reduce feelings of anxiety during their recovery. Proper pain management is important because it can affect how quickly someone can go home from the hospital and their overall satisfaction with their care.
To participate in this trial, women must be between 50 and 70 years old, have good vision and hearing, and be scheduled for elective surgery. They should be able to speak and understand Turkish and must have a certain level of pain after surgery, as measured by a simple scale. However, those with chronic pain, severe anxiety, or certain medical conditions that could make using VR difficult are not eligible to join. This study is not yet recruiting participants, but it aims to explore a new way to improve recovery for women undergoing these common surgeries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 50-70,
- • Being female,
- • Having adequate vision and hearing,
- • Having American Society of Anesthesiologists (ASA) physical status classification I and II,
- • Undergoing elective total knee replacement or hysterectomy surgery,
- • Having a similar analgesia protocol,
- • Being on the first postoperative day,
- • Scoring 5 or higher on the Visual Analogue Scale (VAS) assessment,
- • Being able to speak and understand Turkish.
- Exclusion Criteria:
- • Having chronic pain,
- • Scoring below 5 on the Visual Analogue Scale (VAS) assessment,
- • Experiencing vertigo or motion-sensitive nausea,
- • Being diagnosed with severe anxiety by a specialist physician,
- • Having claustrophobia,
- • Having head or neck conditions that prevent wearing virtual reality goggles,
- • Having a Glasgow Coma Score \<15,
- • Having psychiatric, cognitive, or neurological impairments,
- • Having visual or hearing impairments.
About Osmaniye Korkut Ata University
Osmaniye Korkut Ata University is a leading academic institution dedicated to advancing research and education in the field of health sciences. As a clinical trial sponsor, the university emphasizes rigorous scientific inquiry and ethical standards, fostering collaborations that enhance the development of innovative therapeutic interventions. With a focus on improving patient outcomes and public health, the university leverages its multidisciplinary expertise and state-of-the-art facilities to support clinical research initiatives that address pressing health challenges. Through its commitment to excellence, Osmaniye Korkut Ata University aims to contribute significantly to the global body of medical knowledge and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Merkez, Osmani̇ye, Turkey
Merkez, Osmani̇ye, Turkey
Merkez, , Turkey
Merkez, , Turkey
Patients applied
Trial Officials
Songül GÜNGÖR, Phd
Principal Investigator
Osmaniye Korkut Ata University
Ayşe TAŞTEKİN, associate professor
Study Director
Afyonkarahisar Health Sciences University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported